Konstantin Byrgazov, Chantal Blanche Lucini, Peter Valent, Oliver Hantschel, and Thomas Lion. 2018. “BCR-ABL1 Compound Mutants Display Differential and Dose-Dependent Responses to Ponatinib”. Haematologica 103 (1). Pavia, Italy, e10-e12. https://doi.org/10.3324/haematol.2017.176347.